Literature DB >> 11223270

The present status of exogenous surfactant for the newborn.

A E Curley1, H L Halliday.   

Abstract

This year is the 20th anniversary of the first successful trial of exogenous surfactant for respiratory distress syndrome in the newborn and it is perhaps a good time to review recent advances in basic science and clinical practice as they relate to surfactant therapy.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11223270     DOI： 10.1016/s0378-3782(00)00122-5

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN： 0378-3782            Impact factor:   2.079


  3 in total

1.  Improvement in neonatal intensive care in Northern Ireland through sharing of audit data.

Authors:  J Jenkins; F Alderdice; E McCall
Journal:  Qual Saf Health Care       Date:  2005-06

2.  US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks.

Authors:  Greg R Alexander; Michael Kogan; Deren Bader; Wally Carlo; Marilee Allen; Joanne Mor
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

3.  Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.

Authors:  Matthias Ochs; Markus Schüttler; Guido Stichtenoth; Egbert Herting
Journal:  Respir Res       Date:  2006-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.